# Glucocorticoid Therapy in Coronavirus Disease COVID-19 Patients

> **NCT04780581** · PHASE4 · TERMINATED · sponsor: **Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León** · enrollment: 128 (actual)

## Conditions studied

- Corona Virus Infection

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Methylprednisolone

## Key facts

- **NCT ID:** NCT04780581
- **Lead sponsor:** Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-02-01
- **Primary completion:** 2021-11-09
- **Final completion:** 2021-11-09
- **Target enrollment:** 128 (ACTUAL)
- **Why stopped:** Impossibility of reaching the sample size established by protocol
- **Last updated:** 2025-01-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04780581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04780581, "Glucocorticoid Therapy in Coronavirus Disease COVID-19 Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04780581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*